TY - JOUR
T1 - BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines
AU - Tulchin, Natalie
AU - Chambon, Monique
AU - Juan, Gloria
AU - Dikman, Steven
AU - Strauchen, James
AU - Ornstein, Leonard
AU - Billack, Blase
AU - Woods, Nicholas T.
AU - Monteiro, Alvaro N.A.
N1 - Funding Information:
Supported by Inserm and Université de Montpellier I. Confocal microscopy was performed at the MSSM-Microscopy Shared Research Facility supported, in part, with funding from NIH-NCI shared resources grant (1R24CAO95823-01). Work in the Monteiro Lab is funded by NIH grants CA92309 and CA116167 and by grants from the Florida Breast Cancer Coalition Foundation.
PY - 2010/3
Y1 - 2010/3
N2 - The breast and ovarian cancer susceptibility gene BRCA1 encodes a tumor suppressor. BRCA1 protein, which is involved in DNA damage response, has been thought to be found primarily in cell nuclei. In the present investigation, immunohistological studies of BRCA1 protein in frozen breast cancer tissue and MCF7 and HeLa cell lines revealed BRCA1 expression in both nucleoli and nucleoplasmic foci. Immunoelectron microscopic studies of estrogen-stimulated MCF7 cells demonstrated BRCA1 protein localization in the granular components of the nucleolus. Moreover, immunofluorescence of BRCA1 and nucleolin double-labeling showed colocalization in both nucleoli and nucleoplasmic foci in breast tumor cells and asynchronously growing MCF7 and HeLa cells. Multiparameter analysis of BRCA1 and nucleolin in relation to cell cycle position (DNA content) showed expression during G1-S and persistence of BRCA1 during G2/M. After γ-irradiation of MCF7 cells, BRCA1 protein dispersed from nucleoli and nucleoplasmic foci to other nucleoplasmic sites, which did not colocalize with nucleolin. Small interfering RNA-mediated knockdown of BRCA1 protein resulted in decreased immunofluorescence staining, which was confirmed by Western blotting. The observed colocalization of BRCA1 and nucleolin raises new possibilities for the nucleoplasmnucleolus pathways of these proteins and their functional significance.
AB - The breast and ovarian cancer susceptibility gene BRCA1 encodes a tumor suppressor. BRCA1 protein, which is involved in DNA damage response, has been thought to be found primarily in cell nuclei. In the present investigation, immunohistological studies of BRCA1 protein in frozen breast cancer tissue and MCF7 and HeLa cell lines revealed BRCA1 expression in both nucleoli and nucleoplasmic foci. Immunoelectron microscopic studies of estrogen-stimulated MCF7 cells demonstrated BRCA1 protein localization in the granular components of the nucleolus. Moreover, immunofluorescence of BRCA1 and nucleolin double-labeling showed colocalization in both nucleoli and nucleoplasmic foci in breast tumor cells and asynchronously growing MCF7 and HeLa cells. Multiparameter analysis of BRCA1 and nucleolin in relation to cell cycle position (DNA content) showed expression during G1-S and persistence of BRCA1 during G2/M. After γ-irradiation of MCF7 cells, BRCA1 protein dispersed from nucleoli and nucleoplasmic foci to other nucleoplasmic sites, which did not colocalize with nucleolin. Small interfering RNA-mediated knockdown of BRCA1 protein resulted in decreased immunofluorescence staining, which was confirmed by Western blotting. The observed colocalization of BRCA1 and nucleolin raises new possibilities for the nucleoplasmnucleolus pathways of these proteins and their functional significance.
UR - http://www.scopus.com/inward/record.url?scp=77749273747&partnerID=8YFLogxK
U2 - 10.2353/ajpath.2010.081063
DO - 10.2353/ajpath.2010.081063
M3 - Article
AN - SCOPUS:77749273747
SN - 0002-9440
VL - 176
SP - 1203
EP - 1214
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 3
ER -